Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
A fertility monitor is an electronic device that helps women to identify fertile period. They are generally small, portable, battery-operated gadgets that analyze the results of a fertility test. If couples are trying to conceive then knowing female’s own ovulation cycle helps in finding critically important fertile days. For many women, using a fertility monitor can make the process a lot easier for conceiving. It maximizes the chance of getting pregnant during fertile days.
The India fertility monitor market is estimated to be valued at US$ 2.05 million in 2021 and is expected to exhibit a CAGR of 8.4% over the forecast period (2021-2028).
Figure 1. India Fertility Monitor Market Share (%) in Terms of Value, By Region, 2020
High infertility rate in India and growing product approvals & launches are expected to drive the market growth over the forecast period
High infertility rate among Indian female population is expected to propel growth of the India fertility monitor market over the forecast period. For instance, according to the study conducted by Indian National Family Health in 2018, there is an increase in the infertility rate of the female Indian population in recent years. As per this data, infertility rate in total Indian female population was 13.7 in 2004-2005 which has increased to 17.9 in 2014-2016.
Furthermore, major players in the India fertility monitor market have focused on approval and launch of new products to expand their product portfolio in recent years which has fueled the India fertility monitor market.
India Fertility Monitor Market Report Coverage
||Market Size in 2021:
||US$ 2.05 Mn
|Historical Data for:
||2017 to 2019
||2021 to 2028
|Forecast Period 2021 to 2028 CAGR:
||2028 Value Projection:
||US$ 3.60 Mn
- North India: Delhi, Rajasthan, Uttar Pradesh, Jammu & Kashmir, Punjab, Uttaranchal, and Others
- South India: Kerala, Karnataka, Tamil Nadu, and Andhra Pradesh
- East India: Bihar, Jharkhand, West Bengal, and Odisha
- West India: Goa, Gujarat, and Maharashtra
- Central India: Madhya Pradesh and Chhattisgarh
- North East India: Arunachal Pradesh, Nagaland, Manipur, Mizoram, Meghalaya, and Assam
- By Modality: Hand Held, Tabletop
- By Type: Ovulation Predictor Monitor, Urine & Saliva-based Monitor
- By End User: Hospitals, Fertility Clinics, Homecare Settings
EarlySense (A part of Hillrom), Valley Electronics AG, Swiss Precision Diagnostics, Samplytics Technologies Private Limited, Ava AG, Church & Dwight Co. Inc., HiLin Life Products Inc., Quidel Corporation, Advacare Pharma, Pregmate, and UEBE Medical
- High infertility rate in India
- Increasing product approvals and launches
|Restraints & Challenges:
- Restraint: Less precision of fertility monitor devices
- Opportunity: Increasing number of fertility centers in India
Figure 2. India Fertility Monitor Market Share (%), by Modality, 2021
Increasing number of Fertility Centers in India is expected to offer the market growth opportunities over the forecast period
Rising number of fertility centers in India is expected to drive the demand for fertility monitor devices, which in turn is expected to offer lucrative growth opportunities for key players in the India fertility monitor market. For instance, in December 2020, Indira IVF (In-vitro Fertilization), a chain of fertility centers in India, announced the inauguration of the fertility center in five new centers in Tier-III cities, namely Nanded, Warangal, Sirsa, and Gulbarga in Maharashtra, India.
India Fertility Monitor – Impact of Coronavirus (Covid-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 162 million infected individuals worldwide as of May 16, 2021. Due to the coronavirus (COVID-19) pandemic and lockdown in various countries across the globe such as the U.S., European countries, and India has impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sectors, which has been majorly impacted by the pandemic. The lockdowns in various countries such as India have created an economic burden on the private healthcare sector. Healthcare providers are facing challenges with regards to manpower, equipment, consumables, and other resources to ensure safety of patients with other diseases, and declining outpatients’ visits, among others. Moreover, the pandemic has negatively impacted the development, production, and supply of medical device, and affected growth of the healthcare segment of various companies in India. This has led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of fertility monitor devices.
India Fertility Monitor Market - Restraint
Lesser precision of the fertility monitor devices such as ovulation prediction devices and fertility monitor devices is expected to hinder growth of the India fertility monitor market. According to the Apollo Fertility Centers, the fertility centers in India in 2021 stated some of the drawbacks such as lack in predicting the exact date of ovulation and other factor of the fertility monitoring devices. Females aged above 40 have high level of luteinized hormone, as they are close to menopause and thus ovulation prediction kits may fail to detect the ovulation period in females mainly above age 40
Major players operating in the India Fertility Monitor market include EarlySense (A part of Hillrom), Valley Electronics AG, Swiss Precision Diagnostics, Samplytics Technologies Private Limited, Ava AG, Church & Dwight Co. Inc., HiLin Life Products Inc., Quidel Corporation, Advacare Pharma, Pregmate, and UEBE Medical.